| Angela Dawn Vines, APRN-CNS | |
|
3500 Healthplex Pkwy, Suite 200, Norman, OK 73072-9738 | |
| (405) 515-2260 | |
| (405) 307-5610 |
| Full Name | Angela Dawn Vines |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 12 Years |
| Location | 3500 Healthplex Pkwy, Norman, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942648324 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SA2100X | Clinical Nurse Specialist - Acute Care | R0058473 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Norman Regional | Norman, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Norman Regional Providers Specialty Care | 5496900706 | 138 |
News Archive
Researchers from the Department of Pediatrics of the University of Granada , in collaboration with another 38 universities and companies from 16 European countries, will study the effects of children's nutrition on the onset of cardiovascular problems, diabetes, obesity, allergies, weak bones, neuromotor functioning and children's behavioural aspects.
ImpactRx, Inc., the pioneering force in measuring the impact of pharmaceutical promotion on the behavior of the nation's highest prescribing physicians, today announced the launch of an application for physicians that provides pharmaceutical companies with timely and actionable insight into drug therapy promotion and treatment activity. ImpactRx is leveraging the capabilities of this newly available smart-phone application by using iPhone with its longitudinal physician network.
The U.S. Food and Drug Administration (FDA) today announced the approval of Tekturna (aliskiren) tablets for the treatment of high blood pressure, or hypertension, which affects an estimated 25 percent of Americans and causes increased risk of stroke, heart attack, kidney failure, heart failure and death.
DiagnoCure Inc., a life sciences company commercializing high‐value cancer diagnostic tests and delivering lab services, today announced positive initial results of a multi-center clinical study of 241 stage II colon cancer patients, a population categorized as low risk by traditional methods yet with an average recurrence rate of 20%.
A historic rise in high-deductible health insurance plans has US hospitals struggling to give newly price-conscious patients an accurate estimate of their share of healthcare costs. At the same time, with an increasing share of their revenue dependent on patients, hospitals are accelerating efforts to collect patient payments up front to prevent bad debts.
› Verified 8 days ago
| Entity Name | Norman Regional Providers Specialty Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548513773 PECOS PAC ID: 5496900706 Enrollment ID: O20130312000200 |
News Archive
Researchers from the Department of Pediatrics of the University of Granada , in collaboration with another 38 universities and companies from 16 European countries, will study the effects of children's nutrition on the onset of cardiovascular problems, diabetes, obesity, allergies, weak bones, neuromotor functioning and children's behavioural aspects.
ImpactRx, Inc., the pioneering force in measuring the impact of pharmaceutical promotion on the behavior of the nation's highest prescribing physicians, today announced the launch of an application for physicians that provides pharmaceutical companies with timely and actionable insight into drug therapy promotion and treatment activity. ImpactRx is leveraging the capabilities of this newly available smart-phone application by using iPhone with its longitudinal physician network.
The U.S. Food and Drug Administration (FDA) today announced the approval of Tekturna (aliskiren) tablets for the treatment of high blood pressure, or hypertension, which affects an estimated 25 percent of Americans and causes increased risk of stroke, heart attack, kidney failure, heart failure and death.
DiagnoCure Inc., a life sciences company commercializing high‐value cancer diagnostic tests and delivering lab services, today announced positive initial results of a multi-center clinical study of 241 stage II colon cancer patients, a population categorized as low risk by traditional methods yet with an average recurrence rate of 20%.
A historic rise in high-deductible health insurance plans has US hospitals struggling to give newly price-conscious patients an accurate estimate of their share of healthcare costs. At the same time, with an increasing share of their revenue dependent on patients, hospitals are accelerating efforts to collect patient payments up front to prevent bad debts.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Angela Dawn Vines, APRN-CNS Po Box 1330, Norman, OK 73070-1330 Ph: (405) 515-2260 | Angela Dawn Vines, APRN-CNS 3500 Healthplex Pkwy, Suite 200, Norman, OK 73072-9738 Ph: (405) 515-2260 |
News Archive
Researchers from the Department of Pediatrics of the University of Granada , in collaboration with another 38 universities and companies from 16 European countries, will study the effects of children's nutrition on the onset of cardiovascular problems, diabetes, obesity, allergies, weak bones, neuromotor functioning and children's behavioural aspects.
ImpactRx, Inc., the pioneering force in measuring the impact of pharmaceutical promotion on the behavior of the nation's highest prescribing physicians, today announced the launch of an application for physicians that provides pharmaceutical companies with timely and actionable insight into drug therapy promotion and treatment activity. ImpactRx is leveraging the capabilities of this newly available smart-phone application by using iPhone with its longitudinal physician network.
The U.S. Food and Drug Administration (FDA) today announced the approval of Tekturna (aliskiren) tablets for the treatment of high blood pressure, or hypertension, which affects an estimated 25 percent of Americans and causes increased risk of stroke, heart attack, kidney failure, heart failure and death.
DiagnoCure Inc., a life sciences company commercializing high‐value cancer diagnostic tests and delivering lab services, today announced positive initial results of a multi-center clinical study of 241 stage II colon cancer patients, a population categorized as low risk by traditional methods yet with an average recurrence rate of 20%.
A historic rise in high-deductible health insurance plans has US hospitals struggling to give newly price-conscious patients an accurate estimate of their share of healthcare costs. At the same time, with an increasing share of their revenue dependent on patients, hospitals are accelerating efforts to collect patient payments up front to prevent bad debts.
› Verified 8 days ago
Gina Marie Grady, MSN APRN-CNS Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 3650 W Rock Creek Rd, Norman, OK 73072 Phone: 405-701-4909 Fax: 405-310-6161 | |
Mrs. Carleeta Yvonne Nelson, C.N.S Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 500 E Robinson St, Suite 2600, Norman, OK 73071 Phone: 405-364-6432 Fax: 405-364-0090 | |
Mrs. Stacy Lynn Boothe, CNS Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 3500 Healthplex Pkwy, Suite 200, Norman, OK 73072 Phone: 405-515-2222 Fax: 405-515-2251 | |
Teresa Lea Sherman, APRN, CNS Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 313 Towry Dr, Norman, OK 73069 Phone: 405-590-6449 | |
Amanda Gail Henry, APRN-CNS Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 901 N Porter Ave, Norman, OK 73071 Phone: 405-307-3863 Fax: 405-307-3841 | |
Laura Lee Velez, CNS Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 3500 Healthplex Pkwy, Suite 200, Norman, OK 73072 Phone: 405-360-3089 Fax: 405-360-6765 | |
Alicia D Johnson, APRN-CNP Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 3500 Healthplex Pkwy, Suite 200, Norman, OK 73072 Phone: 405-515-2260 Fax: 405-307-5617 |